Castle Biosciences, Inc.
CSTL
$18.63
-$0.41-2.15%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.63% | 4.16% | 4.21% | 0.28% | -6.13% |
| Total Receivables | -2.06% | -12.23% | -4.93% | -6.39% | 9.91% |
| Inventory | 2.02% | 18.54% | 3.39% | 22.15% | -15.81% |
| Prepaid Expenses | 92.40% | -35.90% | -3.31% | 6.00% | 47.57% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.92% | 0.99% | 2.55% | -0.21% | -2.99% |
|
|
|||||
| Total Current Assets | -8.92% | 0.99% | 2.55% | -0.21% | -2.99% |
| Net Property, Plant & Equipment | 2.78% | 12.20% | 11.69% | 34.51% | 6.19% |
| Long-term Investments | -0.01% | 0.01% | -0.01% | 0.00% | 0.00% |
| Goodwill | -0.01% | 0.01% | -0.01% | 0.00% | 0.00% |
| Total Other Intangibles | -2.50% | -2.50% | -2.43% | 39.01% | -29.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.78% | 69.48% | 40.41% | 4.72% | 5.59% |
| Total Assets | -5.32% | 2.80% | 3.31% | 8.57% | -5.56% |
|
|
|||||
| Total Accounts Payable | -19.63% | 53.23% | -7.36% | 55.03% | 23.20% |
| Total Accrued Expenses | -42.06% | 19.29% | 21.43% | 30.95% | -38.57% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 58.41% | 27.26% | -58.78% | 38.06% | 24.56% |
| Total Finance Division Other Current Liabilities | 54.43% | -21.33% | 25.54% | 24.88% | 40.19% |
| Total Other Current Liabilities | 54.43% | -21.33% | 25.54% | 24.88% | 40.19% |
| Total Current Liabilities | -29.00% | 24.17% | 8.68% | 36.53% | -24.53% |
|
|
|||||
| Total Current Liabilities | -29.00% | 24.17% | 8.68% | 36.53% | -24.53% |
| Long-Term Debt | -12.87% | -4.07% | 24.12% | -9.25% | -8.46% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -0.50% | -0.43% | -0.39% | 79.04% | -1.90% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -0.26% | -19.13% | 2.51% | 452.69% | -47.92% |
| Total Liabilities | -19.77% | 12.47% | 7.15% | 45.50% | -18.56% |
|
|
|||||
| Common Stock & APIC | 0.78% | 0.89% | 1.77% | 1.60% | 1.59% |
| Retained Earnings | -6.47% | -1.05% | -0.23% | 2.00% | -12.92% |
| Treasury Stock & Other | -123.60% | 11.25% | 515.38% | -70.23% | -43.04% |
| Total Common Equity | -2.01% | 0.82% | 2.56% | 3.42% | -3.41% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -2.01% | 0.82% | 2.56% | 3.42% | -3.41% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -2.01% | 0.82% | 2.56% | 3.42% | -3.41% |
|
|
|||||